发明名称 Self-regulated apoptosis of inflammatory cells by gene therapy
摘要 This invention relates to chimeric nucleic acids and to the therapeutic induction of apoptosis in activated inflammatory cells, or cells at a site of inflammation, by introducing into those cells the chimeric nucleic acid. The chimeric nucleic acid having at least one TNFalpha promoter enhancer attached to a functional copy of a TNFalpha promoter and further attached to at least one copy of an apoptosis-inducing gene, which is further attached to a 3'UTR. The apoptosis-inducing gene is Granzyme B. The invention also relates to methods of making and using self-regulated apoptosis chimeric nucleic acids and pharmaceutical compositions containing them for treating inflammatory diseases.
申请公布号 US6537784(B1) 申请公布日期 2003.03.25
申请号 US19990229151 申请日期 1999.01.12
申请人 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. 发明人 TATAKE REVATI J.;MARLIN STEVEN D.;BARTON RANDALL W.
分类号 C12N15/09;A61K31/7088;A61K38/00;A61K48/00;A61P1/04;A61P3/10;A61P17/06;A61P25/00;A61P29/00;A61P31/00;A61P43/00;C07K14/525;C12N5/10;C12N9/64;C12N15/85;C12Q1/68;(IPC1-7):C12P19/34;C12N15/64;C12N15/00;C12Q1/02;C07H21/04 主分类号 C12N15/09
代理机构 代理人
主权项
地址